The Worldwide Insulin Patch Pumps Industry is Expected to Reach $1.7 Billion by 2027 - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Insulin Patch Pumps Market Research Report by Mode, by Product Type, by Region - Global Forecast to 2027 - Cumulative Impact of COVID-19" report has been added to ResearchAndMarkets.com's offering.

The Global Insulin Patch Pumps Market size was estimated at USD 872.89 million in 2020 and expected to reach USD 957.82 million in 2021, at a CAGR of 10.16% to reach USD 1,718.71 million by 2027.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Insulin Patch Pumps Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Insulin Patch Pumps Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Insulin Patch Pumps Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Insulin Patch Pumps Market?

4. What is the competitive strategic window for opportunities in the Global Insulin Patch Pumps Market?

5. What are the technology trends and regulatory frameworks in the Global Insulin Patch Pumps Market?

6. What is the market share of the leading vendors in the Global Insulin Patch Pumps Market?

7. What modes and strategic moves are considered suitable for entering the Global Insulin Patch Pumps Market?

Market Dynamics

Drivers

• Rising incidence and prevalence of diabetes
• Need for ease in the delivery of insulin
• Increasing assistance from various governments

Restraints

• Rise in insulin cost with unfavorable insurance policies

Opportunities

• Advancement in diabetes management devices
• Growing investment to develop technically advanced patch pumps
• Use of artificial intelligence and availability of custom-made patch pumps

Challenges

• Less user friendliness due to complexity of the device

Companies Mentioned

• 3M Company
• Abbott Laboratories Inc.
• Allscripts Healthcare Solutions, Inc.
• B. Braun Melsungen AG
• Becton, Dickinson and Company
• Boston Scientific Corp
• Cardinal Health, Inc.
• CeQur SA
• Debiotech S.A.
• EOFLOW CO. LTD
• Hoffmann-La Roche AG
• Insulet Corporation
• Johnson & Johnson
• Medtronic PLC
• Roche Diagnostics Corporation
• Sanofi SA
• Sooil Development Co., Ltd.
• Tandem Diabetes Care, Inc.
• Thales Group
• Unilife Corporation
• Zealand Pharma A/S

For more information about this report visit https://www.researchandmarkets.com/r/4042qx